Targeting CCL5 in inflammation

Author： Marques Rafael Elias   Guabiraba Rodrigo   Russo Remo Castro   Teixeira Mauro Martins  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.17, Iss.12, 2013-12, pp. : 1439-1460

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting CCL11 in the treatment of ovarian cancer

By Nolen Brian M   Lokshin Anna E  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 2, 2010-02 ,pp. : 157-167

Informa Healthcare

Access to resources Recommend Favorite

Targeting liver X receptors in inflammation

By Steffensen Knut R   Jakobsson Tomas   Gustafsson Jan-Åke  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 8, 2013-08 ,pp. : 977-990

Informa Healthcare

Access to resources Recommend Favorite

Targeting leukotriene B4 in inflammation

By Di Gennaro Antonio   Haeggström Jesper Z  

Expert Opinion on Therapeutic Targets, Vol. 18, Iss. 1, 2014-01 ,pp. : 79-93

Informa Healthcare

Access to resources Recommend Favorite

Targeting Chemoattractant Receptors in Allergic Inflammation

By  

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 2, 2005-04 ,pp. : 163-167

Bentham Science Publishers

Access to resources Recommend Favorite

Agents targeting inflammation in heart failure

By Gullestad Lars   Kjekshus John   Damås Jan Kristian   Ueland Thor   Yndestad Arne   Aukrust Pål  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 5, 2005-05 ,pp. : 557-566

Informa Healthcare

Access to resources Recommend Favorite